Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors

Details for Australian Patent Application No. 2004260738 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Willems, Marc; Vandermaesen, Nele; Love, Christopher John; Freyne, Eddy Jean Edgard; Embrechts, Werner Constant Johan; Buijnsters, Peter Jacobus Johannes Antonius; Cooymans, Ludwig Paul

Agent Shelston IP

Pub. Number AU-B-2004260738

PCT Pub. Number WO2005/012307

Priority PCT/EP03/50310 16.07.03 EP

Filing date 12 July 2004

Wipo publication date 10 February 2005

Acceptance publication date 16 July 2009

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/5025 (2006.01) - ortho- or peri-condensed with heterocyclic ring systems

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

Event Publications

9 March 2006 PCT application entered the National Phase

  PCT publication WO2005/012307 Priority application(s): WO2005/012307

16 July 2009 Application Accepted

  Published as AU-B-2004260738

12 November 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004260739-Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors

2004260737-Babesia vaccines